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Abstract: The 18 kDa translocator protein (TSPO) is an evolutionary conserved cholesterol binding
protein localized in the outer mitochondrial membrane. It has been implicated in the regulation of
various cellular processes including oxidative stress, proliferation, apoptosis, and steroid hormone
biosynthesis. Since the expression of TSPO in activated microglia is upregulated in various
neuroinflammatory and neurodegenerative disorders, we set out to examine the role of TSPO
in an immortalized human microglia C20 cell line. To this end, we performed a dual approach and
used (i) lentiviral shRNA silencing to reduce TSPO expression, and (ii) the CRISPR/Cas9 technology
to generate complete TSPO knockout microglia cell lines. Functional characterization of control
and TSPO knockdown as well as knockout cells, revealed only low de novo steroidogenesis in C20
cells, which was not dependent on the level of TSPO expression or influenced by the treatment
with TSPO-specific ligands. In contrast to TSPO knockdown C20 cells, which did not show altered
mitochondrial function, the TSPO deficient knockout cells displayed a significantly decreased
mitochondrial membrane potential and cytosolic Ca2+ levels, as well as reduced respiratory function.
Performing the rescue experiment by lentiviral overexpression of TSPO in knockout cells, increased
oxygen consumption and restored respiratory function. Our study provides further evidence for a
significant role of TSPO in cellular and mitochondrial metabolism and demonstrates that different
phenotypes of mitochondrial function are dependent on the level of TSPO expression.
Keywords: TSPO; mitochondria; knockdown; knockout; mitochondrial membrane potential;
Ca2+ homeostasis; oxidative phosphorylation; steroid synthesis
1. Introduction
The translocator protein 18 kDa (TSPO) is a highly conserved multifunctional protein residing
in the outer mitochondrial membrane [1]. It is expressed to varying degrees in multiple tissues,
with the highest levels of expression found in steroidogenic tissues, and rather low expression in
the central nervous system. In the brain, TSPO can be detected predominantly in microglia and
reactive astrocytes [2], where the expression is additionally upregulated in the context of inflammation,
neurodegeneration, and malignant neoplasia. In this regard, TSPO is considered as both a diagnostic
biomarker, as well as a therapeutic target [3] within the promising field of theranostics [4].
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Based on its initial function, the protein is named for its ability to translocate cholesterol into the
mitochondrial matrix. Although the role of TSPO in de novo steroidogenesis was questioned in view
of various genetic TSPO deletion models [5–8], our recent study support a role of TSPO expression as
well as TSPO ligands in the regulation of pregnenolone synthesis in mouse BV-2 microglia cells [9].
Beside its suggested role on cholesterol transport and steroid synthesis [8,10,11], TSPO has been shown
to be involved in the regulation of various cellular and mitochondrial functions. The multifunctional
nature of TSPO also implicate mitochondrial bioenergetics (oxidative phosphorylation, OXPHOS) and
metabolism [12], beta-oxidation of fatty acids [13], the production of reactive oxygen species (ROS) [14],
and Ca2+ homeostasis [15]. Moreover, TSPO is also involved in regulating cellular downstream
processes such as proliferation, survival, and apoptosis [3,16].
To investigate the functional role of TSPO within primary human microglia cells, we used
immortalized C20 microglia cells as a model [17], and generated a TSPO shRNA cell line with reduced
TSPO expression and two TSPO deficient knockout cell lines by means of CRIPR/Cas9 technology. By
comparing C20 wildtype/scramble controls with both TSPO knockdown and TSPO deficient knockout
cell lines, we analyzed the effect of TSPO expression on de novo steroidogenesis, mitochondrial
respiration, mitochondrial membrane potential and Ca2+ homeostasis, as well as on the proliferation
of the microglia cells. We found that in contrast to mouse microglia cells, TSPO has no effect on the de
novo steroidogenesis in human C20 microglia cells. Moreover, TSPO strongly regulates mitochondrial
bioenergetics and Ca2+ homeostasis as well as proliferation. Our findings are in line with the hypothesis
that the particular role of this multifunctional protein in a given cell may be dependent on the level of
expression as well as on the type of tissue and respective species.
2. Results
2.1. Lentiviral shRNA TSPO Knockdown and CRSPR/Cas9-Mediated Knockout of TSPO
To study the role and function of TSPO in human microglia cells, we performed a lentiviral shRNA
TSPO knockdown, which led to strongly reduced TSPO protein levels as demonstrated in Western blot
and immunofluorescence in transduced cells (Figure 1A,B). As a mitochondrial marker, Anti-ATPB
(ATP synthase subunit B) immunostaining demonstrates well the mitochondrial network in scramble
control and shRNA TSPO knockdown cells. In a parallel approach, different guide RNAs (gRNAs)
against the TSPO gene were designed (Supplementary Table S1). gRNAs were transfected into human
microglial C20 cells and CRISPR/Cas9-mediated knockout of TSPO was validated by Western Blot
and DNA sequencing of PCR products. In one clone, a combination of gRNA 2 and 7 deleted a 64 bp
fragment, which resulted in a shift in the open reading frame in allele 1. An additional insertion of 235
bp in allele 2 generated an immediate stop codon. A second clone demonstrated an 8 bp deletion in
allele 1 and a deletion of a 64 bp fragment in allele 2, which resulted in a frame shift and generated a
non-functional TSPO gene (Figure 1C). Western blot analysis of TSPO protein expression in both clones
revealed a complete loss of TSPO in the mutated cell lines KO1 and KO2, whereas C20 wildtype cells
showed a prominent TSPO expression at 18 kDa (Figure 1D). TSPO knockout was also validated by
immunofluorescence. Again, anti-ATPB fluorescence demonstrates nicely the mitochondrial network
in C20, KO1 and KO2 cells. TSPO expression as indicated by anti-TSPO antibody is only visible in
C20 wildtype, but is completely missing in KO1 and KO2 cells, validating the loss of TSPO expression
in mutated C20 cells (Figure 1E). Therefore, we considered both the C20 TSPO knockdown as well
as the TSPO knockout cell lines as a viable and promising tool to study the role of TSPO in human
microglia cells.
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Figure 1. Translocator protein 18 kDa (TSPO) gene depletion and deletion in C20 human microglia 87 
cells. (A) TSPO gene lentiviral knockdown resulted in robust reduction of TSPO protein levels. Beta 1 88 
tubulin was used as loading control. (B) Reduced levels of TSPO protein in TSPO knockdown (KD) 89 
cells in comparison to TSPO scramble (SCR) control were also evident in immunofluorescent 90 
co-staining using ATPB antibody. (C) Schematic diagram showing CRISPR/Cas9 guide RNA 91 
targeting sites on the exon 2 of the TSPO gene. Guide DNA targeting sites are highlighted in cyan 92 
and yellow, and start codon of TSPO gene in blue. Successful TSPO knockout in both alleles using 93 
CRISPR/Cas9 system was confirmed by DNA sequencing. (D) Western blot analysis of TSPO in C20 94 
wt and KO1 and KO2 knockout cells reveal complete lack of TSPO expression. (E) TSPO gene 95 
deletion was further confirmed with TSPO antibody co-staining using ATPB as mitochondrial 96 
marker. Scale bars: 20 µm. 97 
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2.2. Effect of TSPO Expression and TSPO Ligands on Steroid Synthesis in human C20 Microglia Cells
Glial cells play a prominent role in neurosteroidogenesis [18–20]. TSPO is highly expressed in
activated glia cells is reported to regulate the synthesis of pregnenolone [8–10,21]; thus, we aimed to
investigate the role of TSPO in and the effect of TSPO ligands on pregnenolone synthesis in human
microglia C20 cells. By means of pregnenolone ELISA, we detected only low levels of pregnenolone in
the supernatant of unstimulated C20 wildtype cells (1.10 ± 0.1 ng/mL) after 6 h incubation with the
3β-hydroxysteroid dehydrogenase-inhibitor trilostane, which was used to prevent further metabolism
of pregnenolone (Figure 2A). Interestingly, the TSPO knockdown as well as the TSPO-deficient cell
lines KO1 and KO2 demonstrated a similar low pregnenolone concentration (KD: 1.05 ± 0.04 ng/mL;
KO1: 1.17 ± 0.22 ng/mL; KO2: 1.10 ± 0.13 ng/mL) compared with the C20 wildtypes (Figure 2A).
In contrast to C20, the steroidogenic cell line H295R (adrenocortical carcinoma cell line) [22], which
we used as a positive control, released a substantially higher amount of pregnenolone leading to a
concentration of 43.9 ± 0.54 ng/mL in the supernatant. Additional activation of the protein kinase A
cascade by dibutyryl-cAMP markedly increased pregnenolone synthesis (Figure 2B).
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 126 Figure 2. Pregnenolone synthesis in C20 and H295R cells. (A) There were no significant changes
in basal pregnenolone production between C20 wt and TSPO knock down or knockout cells (-tri.,
without trilostane; n.s., no significance). (B) Pregnenolone synthesis in H295R steroidogenic cells,
which was over 40 times higher in comparison to C20 cells under basal conditions, could be additionally
upregulated in response to cAMP treatment (p < 0.001). (C) Treatment with various TSPO ligands had
no effect on pregnenolone production in C20 microglia cells. (D) Basal pregnenolone production in C20
wt and KO cells was furthermore not affected by cAMP treatment.
Int. J. Mol. Sci. 2019, 20, 3359 5 of 15
Moreover, treating C20 cells with the TSPO ligands XBD173 (1 µM), Ro5-4864 (100 nM), PK11195
(100 nM) or Etifoxine (1 µM) for 24 h did not lead to increased pregnenolone concentrations (Figure 2C),
indicating that the low steroid synthesizing capacity of C20 cells cannot be stimulated by TSPO ligands.
Treating C20 microglia cells with 1 mM dibutyryl-cAMP for 2 h did not stimulate the pregnenolone
synthesis (Figure 2D). Quantitative analysis of cytochrome P450 (CYP11A1) mRNA (the enzyme
which generates pregnenolone by cleaving the side chain from cholesterol) revealed very low levels
(Figure S1), supporting our observation of low steroid synthesizing capacity of our C20 cells. Together,
these observations demonstrate that the human C20 microglia cell line does not produce substantial
amounts of pregnenolone and indicate that TSPO and TSPO ligands do not modulate the low level of
pregnenolone synthesis in C20 cells.
Thus, as a next step, we were interested in the role of TSPO in modulating mitochondrial function
in human C20 cells.
2.3. Role of TSPO in the Modulation of the Mitochondrial Membrane Potential
As a chemo-electrical potential difference between the matrix and the intermembrane space (IMS),
the mitochondrial membrane potential (MMP) serves as an indicator for the bioenergetic state of
mitochondria. The MMP of human microglial C20 cells was analyzed by loading the cells with the
fluorescent dye JC-1. The cationic dye accumulates in the mitochondrial membranes to an extent
which is dependent on the strength of the electric field. In negatively charged (highly energized)
mitochondria, JC-1 molecules form red fluorescing aggregates, while the fluorescence changes to green,
when the dye molecules disaggregate into monomers in response to dissipation of the MMP. The ratio
of the fluorescence signals emitted by the two states of JC-1 is then analyzed as a measure of MMP.
We could demonstrate that KO1 and KO2 TSPO knockout cells showed a significantly reduced
fluorescence of the aggregate form of JC-1 (red fluorescence) (Figure 3A). The ratio of JC-1
fluorescence (Faggregate/monomere) is lower in the TSPO knockout cells, thereby indicating a less
hyperpolarized/negative membrane potential in the mitochondria devoid of TSPO. This significant
effect could only be observed in the TSPO-deficient knockout lines. A mere reduction in TSPO
expression as evident in the TSPO knockdown cell line was not sufficient to affect the MMP in our C20
microglia cells (Figure 3B).
2.4. Impact of TSPO on Cytosolic Ca2+ Homeostasis in C20 Microglia Cells
Due to their negative membrane potential, mitochondria serve as a sink for Ca2+ ions, contribute
to the homeostasis of cytosolic Ca2+, and regulate intracellular Ca2+ signaling [23,24]. In order to
investigate the effect of TSPO expression on basal cytosolic Ca2+ levels in C20 cells, we performed
Fura-2 Ca2+ imaging, and found a significantly higher Fura-2 fluorescence ratio in KO1 and KO2 when
compared to C20 wildtype (Figure 3C). This observation demonstrates a higher cytosolic Ca2+ level in
TSPO knockout cells, which is in accordance with a reduced MMP as shown in Figure 3A and support a
significant role of TSPO in regulating Ca2+-dependent mitochondrial functions. Considering a putative
molecular scenario in which TSPO may function as part of a VDAC-containing supercomplex [25,26] to
regulate Ca2+ homeostasis, we found a significant downregulation of VDAC expression in C20 TSPO
deficient KO cells by performing Western blots with an anti-VDAC1 antibody (Figure 3D). However,
the effect of TSPO on Ca2+ homeostasis was detectable only in TSPO knockout, but not knockdown
C20 cells (Figure 3E).
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(A) TSPO gene deletion resulted in significant reduction of mitochondrial membrane potential in KO
cells (p < 0.001) Treating the cells (C20 wildtype) with the uncoupling agent FCCP (20 µM) reduced
the fluorescence ratio to about 50%, indicating the dynamic range of the JC-1 assay. (B) JC-1 staining
was not changed after lentiviral TSPO knockdown. (C) TSPO knockout cells show significantly higher
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(D) Deletion of TSPO gene leads to decreased expression of VDAC1 (voltage-dependent anion channel)
protein in knockout cells (p < 0.01). (E) Reduction of TSPO protein level in knockdown C20 cells was
not sufficient to alter the level of intracellular calcium.
2.5. Role of TSPO in Mitochondrial Respiration in Human 20 Microglial Cells
The MMP and the proton gradient established at the inner mitochondrial membrane are major
parameters mutually influencing the bioenergetic core functions of mitochondria, which are the electron
transport and ATP synthesis at the inner membrane/matrix interface (oxidative phosphorylation,
OXPHOS). Using the Seahorse XFp Flux Analyzer, we investigated the oxygen consumption in the
presence of TSPO in scramble control C20 cells, and in shRNA TSPO knockdown cells. Specific
substrates and selective enzyme inhibitors reveal the activity and capacity of the individual respiratory
complexes and functional parameters such as the basal and maximal respiration rates, the oxygen
consumption related to ATP synthesis, and the extent of respiratory coupling (oxygen consumption
versus OXPHOS and ATP synthesis). However, we could not find any significant differences in the
mitochondrial respiration of lentivirally transduced TSPO knockdown cells (Figure 4A). However,
comparing wildtype C20 cells with the TSPO-deficient knockout cell lines KO1 and KO2, we found
that TSPO expression significantly affected the mitochondrial respiration. The basal and maximal
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respiration rate, as well as the ATP-related oxygen consumption were significantly reduced in KO1 and
KO2 TSPO knockout cell lines when compared with C20 wildtype microglia (Figure 4B,C). Moreover,
rescuing the TSPO knockout by lentiviral overexpression of TSPO in the KO1 and KO2 knockout cells
lines restored the TSPO protein expression in transduced cells (Figure 4D). Interestingly, KO1 and
KO2 C20 cells overexpressing the TSPO protein showed an increased oxygen consumption, which
was not different from the C20 (wildtype) cells after transformation with a GFP-expressing lentivirus
as a control (Figure 4D). Basal and maximal respiration, as well as ATP-related oxygen consumption
reached similar levels in TSPO overexpressing and GFP-expressing (wildtype) controls (Figure 4E).
These findings indicate a direct effect of TSPO on mitochondrial respiration and controls for a putative
CRISPR/Cas9-mediated off-target effect.
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Figure 4. TSPO gene knockout using CRISPR/Cas9 system decreases respiration in human microglia
cells. (A) Knockdown of TSPO did not alter respiration in C20 microglia cells (B) Oxygen consumption
rate (OCR) was signific ntly educed in sever l stages of respiration in TSPO KO cells (p < 0.001).
(C) Basal respiration, maximal respiration, and ATP-related oxygen consumptio were significantly
decreased in TSPO knockout cells (p < 0.001). (D) Overexpression of TSPO in knockout cells resulted in
increased respiration which did not differ from wt cells. (E) Basal respiration, maximal respiration,
and ATP-related oxygen consumption which were reduced in KO cells, reached similar levels in TSPO
overexpressing knockout cells.
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3. Discussion
The translocator Protein 18 kDa (TSPO) is a highly conserved outer mitochondrial membrane
protein and is supposed to be involved in cholesterol transport and steroid hormone synthesis, in
regulation of Ca2+ homeostasis and mitochondrial bioenergetics [8,15]. Species- and tissue-specific
TSPO knock-out models allow to investigate the role of TSPO and the impact of TSPO deletion on
steroidogenesis as well as on specific mitochondrial functions in a defined cellular context [5–9]. Most
available data in the literature originate from rodent models. To focus on the role of TSPO in humans,
we used a human microglia cell line, C20 [17], and generated two TSPO knockout lines by means of
CRISP/Cas9, in addition to a lentiviral TSPO shRNA knockdown cell line. Our study demonstrated
substantial expression of TSPO protein in C20 wildtype microglia cells, which is in agreement with
reports describing the presence of TSPO protein in human glia cells [27,28]. Despite the significant
TSPO expression in our C20 cells, we could not detect prominent levels of pregnenolone, which might
be due to the low expression of cytochrome P450scc expression in C20 microglia. In steroid synthesizing
tissues, this enzyme is responsible for catalyzing the cleavage of cholesterol to generate pregnenolone
as the first steroid hormone to be synthesized in the mitochondrial matrix. However, cytochrome
P450scc is reported to be nearly absent in human microglia [29], preventing substantial de novo
synthesis of pregnenolone from cholesterol in these cells. In the same line of evidence, pregnenolone
levels in C20 TSPO knockout cells were not different from the wildtype microglia cells, and the TSPO
ligands XBD173, Ro5-4864, Pk111965, or Etifoxine did not influence pregnenolone levels neither in
C20 wildtype, nor in TSPO knockout cells. However, a low basal rate of steroid synthesis in C20 cells
could be demonstrated by omitting the 3β-hydroxysteroid dehydrogenase-inhibitor trilostane from
the assay medium, thereby allowing further metabolism of pregnenolone. The low concentration of
pregnenolone in the supernatant in the presence of trilostane was even reduced to 0.2 ng/mL when
pregnenolone can be further metabolized in the absence of trilostane (Figure 2A).
Considering the abundance of TSPO in microglia cells without relevance to de novo steroid
synthesis, we searched for alternative functional roles of TSPO. In this line, we found a robust effect of
TSPO expression on mitochondrial respiration. The basal and the maximal respiration, as well as the
ATP synthesis-related oxygen consumption were clearly and significantly reduced in TSPO deficient
knockout cells compared to C20 wildtype microglia. Our current approach to compare a lentiviral
shRNA knockdown with CRISPR/Cas9-mediated TSPO knockout allowed the analysis of a clear and
defined TSPO deficient phenotype. In a recent study, we used mouse BV-2 TSPO knockdown cells,
and found the basal, maximal, and ATP-related oxygen consumption to be unchanged between TSPO
knockdown and scramble control cells. However, evidence for TSPO being a modulator of cellular
energy metabolism was already reported in an early study from Vorobjev and Zorov, which pointed to
an effect of diazepam as ligand of the peripheral benzodiazepine receptor (PBR) on mitochondrial
respiration in pig kidney embryonal cells [30]. Later, TSPO deficiency was correlated with reduced
basal oxygen consumption in primary microglia which was isolated from genetically modified TSPO
knock-out mice [5]. However, the oxygen consumption rate (OCR) in mitochondria isolated from a
liver-specific conditional TSPO knock-out mouse was not different from control mitochondria [31].
Similarly, mouse MA-10 Leydig cells with eliminated TSPO gene showed no differences in OCR
compared to TSPO expressing control MA-10 cells [7]. In contrast, fibroblasts from global TSPO
knock-out mice showed decreased OCR [32]. Overexpression of TSPO in Jurkat cells led to the
upregulation of proteins involved in electron transport and energy metabolism. This gene regulation
correlates with an increased mitochondrial ATP synthesis and cell proliferation [12]. These studies
indicate that TSPO is able to regulate mitochondrial energy metabolism, but also suggest that the effect
of TSPO on mitochondrial function may depend on cell type and species.
Feeding NADH and FADH2 into the respiratory complexes of the electron transport chain in
the inner mitochondrial membrane (IMM), allows the pumping of protons into the intermembrane
space (IMS), thereby generating a prominent electro-chemical potential difference between the matrix
and IMS [33]. This mitochondrial membrane potential (MMP) is an important functional parameter
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which influences ATP synthesis and Ca2+ homeostasis. We found that knocking out TSPO in human
C20 microglia cells led to a robust and significant reduction of the mitochondrial membrane potential.
The reduced MMP also correlates with lower respiratory activity (see above) and with reduced Ca2+
retaining capacity, which would mechanistically lead to an increased basal cytosolic Ca2+ level [34].
A similar effect of TSPO expression on the MMP was found in mouse BV-2 microglia, where a lentiviral
knockdown of TSPO led to a reduced potential difference [9], and TSPO deficient murine fibroblasts
as well as Leydig cells also demonstrated a reduced MMP [35]. In a rat model of cortical contusion,
TSPO expression was correlated with the loss of MMP and affected by the TSPO agonist PK11195 [36].
In addition, TSPO has also been shown to regulate dynamic Ca2+ signaling in various cell types and
species. Both TSPO overexpression and knockdown affected ATP-induced mitochondrial Ca2+ transients
in canine epithelial cells and correlated with the mitochondrial membrane potential difference [15].
In general, mechanisms that are engaged in regulating MMP, Ca2+ homeostasis, mitochondrial
respiration, and bioenergetics may involve an interaction of TSPO with other proteins such as VDAC
and ANT [37,38], ACBD3, and PKA [15,39]. TSPO may modulate ATP synthase via a direct interaction
between the ATP synthasome complex (composed of ATP synthase, phosphate carrier, and ANT) and
the PBR complex composed of TSPO, VDAC, and ANT [12,40,41]. Importantly, VDAC constitutes
the principle pathway in the OMM for the transport and exchange of ions, ADP, and ATP, as well as
metabolites and substrates. Its Ca2+ permeability has been shown to be regulated in a TSPO-dependent
way by PKA-mediated phosphorylation [15]. Interestingly, we found a reduced VDAC1 expression
associated with the TSPO knockout in our C20 cells. This correlation may also basically contribute to
the mechanism of TSPO action on mitochondrial physiology.
In summary, our findings demonstrate that human C20 microglia cells show only low de novo
synthesis of pregnenolone. Residual pregnenolone levels in C20 do not correlate with TSPO expression or
treatment with canonical TSPO ligands. However, TSPO plays a significant role in the regulation of the
MMP, Ca2+ homeostasis, and energetic metabolism. Moreover, when considering reports showing the
mammalian TSPO being able to substitute for the bacterial version in negatively regulating photosynthesis
genes in response to oxygen [42], it may become evident that TSPO function varies in different species
and cell types, probably depending on the dynamic interaction with different proteins and the changing
architecture of interacting signaling complexes. This will be in the focus of our future studies.
4. Materials and Methods
4.1. Cell Lines and Culture Conditions
Human microglia C20 cells [17] were grown in Dulbecco’s Modified Eagle’s Medium/Nutrient
Mixture F-12 Ham (Sigma Aldrich, Taufkirchen, Germany), supplemented with 10% fetal calf serum
(FCS), 2mM L-glutamine, 10,000 U/mL penicillin-streptomycin at 37 ◦C, humidified air and 5% CO2.
Adrenocortical carcinoma NCI-H295R cells (CLS, Eppelheim, Germany) were cultured in DMDM/F12
medium containing 15mM HEPES, 6.25 µg/mL insulin, 6.25 µg/mL transferrin, 6.25 ng/mL selenium,
1.25 mg/mL BSA, 5.35 mg/mL linoleic acid, and 2.5% Nu-Serum I, supplemented with 100 U/mL
penicillin and 0.1 mg/mL streptomycin, (Thermo Fischer Scientific, Darmstadt, Germany). The cells
were maintained in humidified air (5 % CO2) at 37 ◦C, and medium was changed three times a week.
4.2. CRISPR/Cas9-Mediated TSPO Knockout
CRISPR/Cas9 genome editing experiments in C20 cells were performed with lipofection of
high-fidelity (hiFi) Cas9 (Integrated DNA Technologies, Inc.) ribonucleoprotein (RNP) complex as
described previously (Vakulskas et al. 2018; DOI 10.1038/s41591-018-0137-0). Briefly, guide RNAs
were designed using web tool (https://zlab.bio/guide-design-resources) (access on 28.02.2017), and
combined with tracrRNA (Integrated DNA Technologies, Inc., Coralville, IA, USA) in equal amounts
in IDT Duplex Buffer (30 mM HEPES, pH 7.5, 100 mM Potassium Acetate) at 1 µM concentration by
heating the oligos to 95 ◦C for 5 min and slowly cooling to room temperature. RNP complexes were
Int. J. Mol. Sci. 2019, 20, 3359 10 of 15
formed by the addition of HiFi Cas9 enzyme, and C20 cells were transfected using RNAiMax (Thermo
Fischer Scientific, Dreieich, Germany) transfection reagent. After 2 days the cells were singled out for
clonal selection. Single clones were collected, and the successful knockout was confirmed by western
blot using anti rabbit TSPO antibody and sequencing of genomic DNA.
4.3. Lentiviral TSPO Knockdown and Overexpression of TSPO in TSPO Knockout Cells
The TSPO knockdown lentiviral expression vector (pLKO-shTSPO) was constructed by replacing
the original 1.9 kb stuffer in the pLKO.1 vector using AgeI/EcoRI restriction enzymes by short hairpin
double-stranded oligo using the following primers:
shTSPO-F: 5’-CCGGCCACACTCAACTACTGCGTATCTCGAGATACGCAGTAGTTGAGTGT
GGTTTTTG-3’
shTSPO-R: 5’-AATTCAAAAACCACACTCAACTACTGCGTATCTCGAGATACGCAGTAGTTGA
GTGTGG-3’
pLKO.1-TRC cloning vector was a gift from David Root (Addgene plasmid #10878). The design of
the human TSPO shRNA was taken from the RNAi Consortium (Moffat et al., 2006) (Cambridge, UK)
with the clone ID (TRCN0000060433). The scramble shRNA was a gift from David Sabatini (Addgene
plasmid #1864).
The lentiviral TSPO overexpression vector was constructed by replacing the GFP gene in
the pLJM1-GFP plasmid (Addgene plasmid #19319) with human TSPO using hTSPO-AgeI-F, and
hTSPO-EcoRI-R primers (Supplementary Table S1).
Twenty-four hours before transfection, 2.2 × 106 HEK293T cells were seeded onto a 100 mm
culture dish. Using a standard calcium phosphate transfection protocol, 10 µg of the pLKO.1-shTSPO
or pLJM1-TSPO vector, 7.5 µg of psPAX2 (Addgene plasmid #12260), and 2.5 µg of pMD2.G (Addgene
plasmid #12259) plasmid were co-transfected into HEK293T cells. Virus-containing supernatants were
collected 48 h after transfection, and were immediately aliquoted and stored at −80 ◦C. The titer of
lentiviral preparation was determined with colony formation assay using 2 µg/mL puromycin selection
and 0.1% Crystal Violet staining solution. Lentiviral transduction was performed by spinoculation
at 2400 rpm for 60 min by adding virus solution to cells at the multiplicity of infection of 3–5, which
did not show toxic effects on the cells, in the presence of 8 µg/mL polybrene. Fresh C20 culture
medium containing a 2 µg/mL of puromycin was added to cells 24 h after infection; cells remained
under selection until all the mock-transfected cells died. Surviving cells were pooled and cultured for
further analysis.
4.4. Immunofluorescence
C20 wildtype or TSPO knockdown/knockout cells were grown for 24 h on sterile glass coverslips
and fixed for 10 min at room temperature with 4% (w/v) paraformaldehyde (Carl Roth GmbH, Karlsruhe,
Germany). After washing, cells were permeabilized with blocking/permeabilization solution (10%
(v/v) goat serum, 0.5% (v/v) Triton X-100 in 1 × PBS) for 20 min. Cells were then incubated overnight, at
4 ◦C with rabbit-anti-TSPO antibody (ab109497) and mouse-anti-ATPB antibody (ab14730), both from
Abcam, Cambridge, UK, diluted 1:1000 in 2% goat serum and 0.1% Triton X-100 in 1 × PBS. After three
additional washing steps, cells were incubated for 1 h with secondary antibodies conjugated with Alexa
Fluor 488 and Cy3 (Life Technologies, Carlsbad, CA, USA, both diluted 1:1000 in 2% goat serum and
0.1% Triton X-100 in 1 × PBS. Nuclei were labeled with Hoe33342 (AppliChem, Darmstadt, Germany)
at a final concentration of 0.1 ug/mL in 1 x PBS. Finally, cells were mounted with confocal matrix (Micro
Tech Lab, Graz, Austria) and examined with an inverted fluorescence microscope (Observer.Z1, ZEISS,
Jena, Germany). An XBO 175 W served as the light source (Lambda DG4, Sutter instruments, Novato,
CA, USA). Images were taken by a ZEISS AxioCam MRm CCD camera using the ZEN software (ZEISS).
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4.5. Western Blotting
Whole cell protein samples were sonicated and boiled in RIPA buffer and total protein was
quantified using a micro-BCA colorimetric assay (Pierce, Thermo Fischer Scientific, Dreieich,
Germany). Protein samples were separated by SDS-polyacrylamide gel electrophoresis on 15%
gels and subsequently transferred onto Immobilon®-P PVDF membrane (Millipore, Bedford, MA,
USA). Incubation of rabbit-anti-TSPO (ab109497), mouse-anti-ATPB (ab14730), and mouse-anti-VDAC1
(ab186321) antibodies, all from Abcam, Cambridge, UK, diluted were performed O.N. at 4 ◦C.
4.6. RNA Isolation, Reverse Transcription and Quantitative Real-time RT-PCR
Total RNA was extracted using RNA Plus Kit (Macherey-Nagel, Düren, Germany) according to the
manufacturer’s instructions. First strand cDNA synthesis from 1 µg of total RNA was performed with
QuantiTect Reverse Transcription Kit (Qiagen, Hilden, Germany). Quantitative RT-PCR experiments
were performed with Rotor-Gene-Q machine (Qiagen, Hilden, Germany) using the 1x Takyon SYBR
Master Mix (Eurogentec, Köln, Germany), and specific intron-spanning primers, listed in Supplemental
Table S1. Measurements were performed in triplicate and results were analyzed with a Rotor-Gene-Q
software version 2.3 (Qiagen, Hilden, Germany) applying the ∆∆Ct method for relative quantification.
4.7. Pharmacology
The concentration of compounds in the experiments (1 µM XBD173, 100 nM PK11195, 100 nM
Ro5-4864, 1 µM Etifoxine) were adjusted according to [9]. The compounds were dissolved in ethanol
and diluted with assay buffer to the final working concentration (ethanol concentration below 1:1000).
All treatments were compared with solvent control.
4.8. Pregnenolone ELISA
5 × 104 C20 wildtype or TSPO knockout cells were grown in Dulbecco’s Modified Eagle’s Medium/
Nutrient Mixture F-12 Ham (Sigma Aldrich, Taufkirchen, Germany), supplemented with 10% fetal calf
serum (FCS), 2mM L-glutamine, 10 000U/mL penicillin-streptomycin at 37 ◦C, humidified air and 5% CO2,
and incubated with XBD (1 µM), PK11195 (100 nm), Ro5-4864 (100 nm) or Etifoxine (1 µM). After 16 h,
cells were washed with PBS, and kept in pregnenolone assay buffer (140 mM NaCl, 5 mM KCl, 1.8 mM
CaCl2, 1 mM MgSO4, 10 mM glucose, and 10 mM HEPES) containing 25 µM trilostane (Sigma Aldrich) to
inhibit further metabolism of pregnenolone. Cells were treated again with TSPO ligands for additional 6 h.
Then, supernatants were analyzed using an enzyme-linked immunosorbent assay (ELISA) for pregnenolone
quantification, according to the manufacturer’s recommendations (Pregnenolone ELISA, IBL International,
Hamburg, Germany). Assays were read with a Tecan Spectra microplate reader (Tecan, Crailsheim, Germany)
at 450 nm. Data were analyzed by Magellan Data Analysis Software (Tecan, Version 2.0) [9].
4.9. Mitochondrial Membrane Potential
2.5 × 104 C20 wildtype or TSPO knockout cells were seeded on sterile glass coverslips (diameter
25 mm), placed in 6-well plates, and grown overnight in Dulbecco’s Modified Eagle’s Medium/Nutrient
Mixture F-12 Ham at 37 ◦C, humidified air and 5% CO2. Cells were loaded with 200 nM JC-1/Pluronic
(Life Technologies) in Opti-MEM (Life Technologies, Carlsbad, CA, USA) for 30 min at 37 ◦C, humidified
air and 5% CO2. For imaging, coverslips were washed with assay buffer (140 mM NaCl, 5 mM KCl,
1.8 mM CaCl2, 1 mM MgSO4, 10 mM glucose, and 10 mM HEPES) and mounted in a chamber on the
inverted microscope (ZEISS Observer Z.1, Jena, Germany). A Lambda DG4 high-speed wavelength
switcher (Sutter instruments, Novato, USA) allowed the excitation of JC-1 480/36 nm. The emitted light
was filtered at 537/42 nm and 620/60 nm for green or red fluorescence, respectively, and finally detected
by a CCD camera (AxioCam MRm, ZEISS, Jena, Germany). Mitochondrial membrane potential was
analyzed as ratio of red versus green fluorescence intensity in regions of interest, drawn over selected
cells in the visual field using the Zen imaging software (ZEISS) and ImageJ.
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4.10. Ca2+ Imaging
25 × 103 C20 wildtype or TSPO knockout cells were grown in 96-well dishes and loaded with
2 µM Fura-2/AM (Life Technologies, Carlsbad, CA, USA) in opti-MEM for 45 min at 37 ◦C and 5% CO2.
Cytosolic Ca2+ concentration in C20 cells was assessed by measuring the fluorescence at 510 nm after
excitation at 340 or 380 nm in a spectrofluorometer (Tecan Spark, Männedorf, Switzerland).
4.11. Mitochondrial Respirometry
3 × 104 C20 wildtype or TSPO knockout cells were grown in XFp 8-well miniplates (Agilent
Technologies, Waldbronn, Germany) at 37 ◦C, humidified air and 5% CO2. Cartridges were prepared
according to the manufacture’s recommendations. The XFp Cell Mito Stress Test Kit (Agilent
Technologies, Walsbronn, Germany) contained the mitochondrial stress compounds oligomycin
(1 µM), FCCP (2 µM), and rotenone/antimycin A (1 µM). Oxygen consumption rate (OCR) and
extracellular acidification rate (ECAR) were measured by means of a XFp Seahorse Flux Analyzer
(Agilent Technologies).
4.12. Statistical Analysis
Data were expressed as mean ± standard error of the mean. Statistical analysis was performed
with IBM SPSS Statistics 25 and GraphPad Prism8. Statistical significance was assessed using
independent samples t-test, Mann-Whitney U test, or ANOVA, combined with post hoc tests for
multiple comparisons. Results were regarded statistically significant for p < 0.05.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/13/
3359/s1.
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Abbreviations
TSPO Translocator protein 18 kDa
OXPHOS Oxidative phosphorylation
MMP Mitochondrial membrane potential
ROS Reactive oxygen consumption
VDAC Voltage-dependent anion channel
IMM Inner mitochondrial membrane
OMM Outer mitochondrial membrane
KD Knockdown
KO Knockout
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